However, this precept has been questioned recently in GC, as Dr. Qiang showed that overexpression of TAp73 seems to inhibit BAX and NOXA expression, to increase Cyclin D1 expression, and confers resistance to 5-FU and doxorubicin [404,405]. This evidence concerns the gene BAX and gastric cancer.